EQUILLIUM
Equillium Inc is a biotechnology company that develops products for autoimmune and inflammatory, or immuno-inflammatory disorders with an unmet medical need. Its primary product candidate is EQ001, which is a clinical-stage first-in-class monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. CD6 plays a central role in effector T cell activity, which drives a number of immuno-inflammatory diseases such as graft versus host disease, asthma, uveitis, colitis, lupus, and multiple sclerosis.
EQUILLIUM
Social Links:
Industry:
Biopharma Biotechnology Life Science
Founded:
2017-01-01
Address:
La Jolla, California, United States
Country:
United States
Website Url:
http://www.equilliumbio.com
Total Employee:
11+
Status:
Active
Contact:
858 412 5302
Total Funding:
85 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Google Universal Analytics
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Demetrix
Demetrix is a biotechnology company dedicated to researching and producing bioactive ingredients.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-09-06 | Metacrine | Metacrine acquired by Equillium | N/A |
| 2022-02-16 | Bioniz Therapeutics | Bioniz Therapeutics acquired by Equillium | N/A |
Investors List
Decheng Capital
Decheng Capital investment in Post-IPO Equity - Equillium
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Equillium
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Equillium
Official Site Inspections
http://www.equilliumbio.com Semrush global rank: 2.05 M Semrush visits lastest month: 10.18 K
Unable to get host informations!!!
More informations about "Equillium"
Equillium - Home
At Equillium, we leverage a deep understanding of immunobiology and its role in disease to pioneer new products for severe autoimmune and inflammatory disorders with high unmet medical need.See details»
Equillium - Investor Relations
Mar 27, 2025 [email protected]. Quick Links. FAQs; SEC Filings; Investor Email Alerts. To opt-in for investor email alerts, please enter your email address in the field below and select at …See details»
Equillium, Inc. - LinkedIn
Equillium, Inc. | 5,190 followers on LinkedIn. Resetting Balance, Restoring Health | Equillium is a clinical-stage biotechnology company leveraging deep understanding of immunobiology to pioneer ...See details»
Equillium - Crunchbase Company Profile & Funding
Organization. Equillium . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number …See details»
Equillium Company Profile | Management and Employees List
[email protected]: Equillium Top Competitors. Company Employees Revenue Top technologies; Metacrine. 17: $5.7 M: KBP Biosciences. 101: $24.9 M: Alzheon. 26: $3.8 M: …See details»
Equillium, Inc. (EQ) Company Profile & Facts - Yahoo Finance
See the company profile for Equillium, Inc. (EQ) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives …See details»
Equillium, Inc. Overview | SignalHire Company Profile
[email protected]: Phone Number: 858-412-5302: Equillium, Inc. industries Biotech, Biotechnology: Headquarters Location: 2223 Avenida de la Playa, San Diego, California, US …See details»
Equillium - Org Chart, Teams, Culture & Jobs - The Org
Equillium is a clinical-stage biotechnology company leveraging deep understanding of immunobiology to pioneer new products with a mission to dramatically improve the lives of …See details»
Equillium - VentureRadar
Similar Companies: LiliumX United Kingdom Privately Held LiliumX uses a unique protein technology platform to facilitate scalable discovery of first-in-class bispecific biologics. We can …See details»
Equillium CEO and Key Executive Team | Craft.co
Equillium's Co-Founder, Chief Executive Officer, Director is Bruce Steel. Other executives include Jason Keyes, Chief Financial Officer; Daniel M. Bradbury, Co-Founder, Executive Chairman …See details»
Equillium Inc Company Profile - Overview - GlobalData
Equillium Inc (Equillium) is a clinical-stage biotechnology company. It focuses on the development of novel therapeutics for severe autoimmune and inflammatory disorders.See details»
Equillium Company Profile - Craft
Oct 29, 2024 Equillium is a biotechnology company developing products for autoimmune and inflammatory disorders. It offers Itolizumab, amonoclonal antibody that targets the CD6 …See details»
Equillium - Equillium Announces Leadership Updates
Nov 12, 2019 For more information, visit www.equilliumbio.com. Executive Biographies Bruce Steel is a co-founder and director of Equillium, and has served as its president and chief …See details»
Equillium, Inc. - Cruelty Free Investing
Company Website: https://equilliumbio.com Contact: [email protected] ©2025 CrueltyFreeInvesting.org | Cruelty Free Investing is a registered 501c3 Non-Profit Organization …See details»
Equillium - Company info. interviews, news - BiopharmaTrend
Equillium is a biotechnology company leveraging deep understanding of immunobiology to develop products for autoimmune and inflammatory disorders, or immuno-inflammation, with …See details»
Equillium - Overview, News & Similar companies | ZoomInfo.com
Equillium contact info: Phone number: (858) 240-1200 Website: www.equilliumbio.com What does Equillium do? Equillium, Inc., a clinical-stage biotechnology company, develops and sells …See details»
Equillium - workinbiotech.com
Equillium is using advances in immunobiology to create therapeutics to treat autoimmune diseases. A healthy immune system needs to be correctly balanced to ensure it is activated …See details»
Equillium - Equillium Announces Results of the Phase 3 EQUATOR …
Mar 27, 2025 LA JOLLA, Calif.--(BUSINESS WIRE)-- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop …See details»
Equillium pushes for breakthrough status despite missing primary ...
Mar 27, 2025 In the company’s ongoing Phase III placebo-controlled Equator study (NCT05263999), itolizumab was unable to reach complete response (CR) or overall response …See details»
Equillium Strengthens Leadership Team with Key Appointments
Feb 27, 2020 Equillium believes that itolizumab has the potential to be a best-in-class disease modifying therapeutic and is advancing itolizumab into clinical development in the following …See details»